These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23242298)

  • 21. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
    D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
    Mayeux R; Saunders AM; Shea S; Mirra S; Evans D; Roses AD; Hyman BT; Crain B; Tang MX; Phelps CH
    N Engl J Med; 1998 Feb; 338(8):506-11. PubMed ID: 9468467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gender has a strong modulating effect on the risk of Alzheimer's disease conferred by the apolipoprotein E gene in the population of the Canary Islands, Spain].
    Déniz Naranjo MC; Muñoz Fernández C; Alemany Rodríguez MJ; Pérez Viéitez MC; Irurita Latasa J; Suárez Armas R; Suárez Valentín MP; Sánchez García F
    Rev Neurol; 2004 Apr 1-15; 38(7):615-8. PubMed ID: 15098180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect between apolipoprotein E ε4 and diabetes mellitus for dementia: result from a population-based study in urban China.
    Zhao Q; Xiong Y; Ding D; Guo Q; Hong Z
    J Alzheimers Dis; 2012; 32(4):1019-27. PubMed ID: 22890095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies.
    Jacquier M; Arango D; Villareal E; Torres O; Serrano ML; Cruts M; Montañes P; Cano C; Rodriguez MN; Serneels S; Van Broeckhoven C
    Arq Neuropsiquiatr; 2001 Mar; 59(1):11-7. PubMed ID: 11299424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
    O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
    Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease.
    El Shamieh S; Costanian C; Kassir R; Visvkis-Siest S; Bissar-Tadmouri N
    Per Med; 2019 Jan; 16(1):15-23. PubMed ID: 30457419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of APOE polymorphism in the "Paisa" population from northwest Colombia (Antioquia).
    Velez-Pardo C; Rojas W; Jimenez-Del-Rio M; Bedoya G
    Ann Hum Biol; 2015 Mar; 42(2):195-8. PubMed ID: 25026367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of risk factors for Alzheimer's disease: results at 7.5 years.
    Zubenko GS; Winwood E; Jacobs B; Teply I; Stiffler JS; Hughes HB; Huff FJ; Sunderland T; Martinez AJ
    Am J Psychiatry; 1999 Jan; 156(1):50-7. PubMed ID: 9892297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer's disease.
    Arboleda GH; Yunis JJ; Pardo R; Gómez CM; Hedmont D; Arango G; Arboleda H
    Neurosci Lett; 2001 Jun; 305(2):135-8. PubMed ID: 11376902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.
    Reitz C; Patel B; Tang MX; Manly J; Mayeux R; Luchsinger JA
    J Neurol Sci; 2007 Jun; 257(1-2):194-201. PubMed ID: 17328914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.